Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela R Smith

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
Blood|January 14, 2011
Hematopoietic cell transplantation comorbidity index predicts transplantation outcomes in pediatric patientsAngela R Smith, Navneet S Majhail, Margaret L MacMillan, et al.
Frontiers in Immunology|September 27, 2019
Structure Based Prediction of Neoantigen ImmunogenicityTimothy P Riley, Grant L J Keller, Angela R Smith, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 26, 2012
Human parainfluenza virus infection after hematopoietic stem cell transplantation: risk factors, management, mortality, and changes over timeCelalettin Ustun, Jiří Slabý, Ryan M Shanley, et al.
Antimicrobial Agents and Chemotherapy|June 7, 2021
CYP2C19 Phenotype and Body Weight-Guided Voriconazole Initial Dose in Infants and Children after Hematopoietic Cell TransplantationTakuto Takahashi, Maryam A Mohamud, Angela R Smith, et al.
Blood Advances|January 4, 2018
Cadherin 17 mutation associated with leaky severe combined immune deficiency is corrected by HSCTAngela R Smith, Ioanna A Rota, Stefano Maio, et al.
Annals of Hematology|June 12, 2015
Factors associated with hematopoietic cell transplantation (HCT) among patients in a population-based study of myelodysplastic syndrome (MDS) in MinnesotaAngela R Smith, Erica D Warlick, Michelle A Roesler, et al.
Transplantation and Cellular Therapy|March 31, 2021
Phase I Dose-Finding, Safety, and Tolerability Trial of Romiplostim to Improve Platelet Recovery After UCB TransplantationGeorgios E Christakopoulos, Todd E DeFor, Stefanie Hage, et al.
Bone Marrow Transplantation|November 27, 2019
A phase I dose finding study of intravenous voriconazole in pediatric patients undergoing hematopoietic cell transplantationJessica Knight-Perry, Cathryn Jennissen, Susie E Long, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 14, 2010
Early lymphocyte recovery and outcomes after umbilical cord blood transplantation (UCBT) for hematologic malignanciesMichael J Burke, Rachel Isaksson Vogel, Sanyukta K Janardan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 28, 2013
Unrelated donor allogeneic hematopoietic stem cell transplantation for patients with hemoglobinopathies using a reduced-intensity conditioning regimen and third-party mesenchymal stromal cellsSandhya Kharbanda, Angela R Smith, Stephanie K Hutchinson, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
Blood|January 14, 2011
Hematopoietic cell transplantation comorbidity index predicts transplantation outcomes in pediatric patientsAngela R Smith, Navneet S Majhail, Margaret L MacMillan, et al.
Frontiers in Immunology|September 27, 2019
Structure Based Prediction of Neoantigen ImmunogenicityTimothy P Riley, Grant L J Keller, Angela R Smith, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 26, 2012
Human parainfluenza virus infection after hematopoietic stem cell transplantation: risk factors, management, mortality, and changes over timeCelalettin Ustun, Jiří Slabý, Ryan M Shanley, et al.
Antimicrobial Agents and Chemotherapy|June 7, 2021
CYP2C19 Phenotype and Body Weight-Guided Voriconazole Initial Dose in Infants and Children after Hematopoietic Cell TransplantationTakuto Takahashi, Maryam A Mohamud, Angela R Smith, et al.
Blood Advances|January 4, 2018
Cadherin 17 mutation associated with leaky severe combined immune deficiency is corrected by HSCTAngela R Smith, Ioanna A Rota, Stefano Maio, et al.
Annals of Hematology|June 12, 2015
Factors associated with hematopoietic cell transplantation (HCT) among patients in a population-based study of myelodysplastic syndrome (MDS) in MinnesotaAngela R Smith, Erica D Warlick, Michelle A Roesler, et al.
Transplantation and Cellular Therapy|March 31, 2021
Phase I Dose-Finding, Safety, and Tolerability Trial of Romiplostim to Improve Platelet Recovery After UCB TransplantationGeorgios E Christakopoulos, Todd E DeFor, Stefanie Hage, et al.
Bone Marrow Transplantation|November 27, 2019
A phase I dose finding study of intravenous voriconazole in pediatric patients undergoing hematopoietic cell transplantationJessica Knight-Perry, Cathryn Jennissen, Susie E Long, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 14, 2010
Early lymphocyte recovery and outcomes after umbilical cord blood transplantation (UCBT) for hematologic malignanciesMichael J Burke, Rachel Isaksson Vogel, Sanyukta K Janardan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 28, 2013
Unrelated donor allogeneic hematopoietic stem cell transplantation for patients with hemoglobinopathies using a reduced-intensity conditioning regimen and third-party mesenchymal stromal cellsSandhya Kharbanda, Angela R Smith, Stephanie K Hutchinson, et al.
Pageof 7